
1æ¥æ°åã®ãéåã®ã€ãŸã¿é£ããã§ããã«ãªã人ãå°ãªãã£ãïœVILPAãšããäºé²
ãããã«ãªããããªããã§ããã©ãéåã£ãŠäœããããããã§ããã
ãã®è³ªåãå®ã¯ãã£ããé£ããã
ããäºé²ã®ç®å®ã¯ããã¡ãããããç±³åœå¯ŸããåäŒã¯ãæäººã«å¯ŸããŠäžç床ã®éåãé±150ã300åããŸãã¯é«åŒ·åºŠãé±75ã150åããããŠããŠãã§ããã°300åã«å±ããããããè¶ ããã®ãçæ³ãšããŠããã
ã§ããéåç¿æ
£ããªã人ã«ããããã®ãŸãŸèšãã®ã¯ãã€ãèºèºããã
ãé±300åãç®æããŸãããâºïžããšèšãããç¬éã«ããã¶ãéçŸå®çãããŠããæ°ããªãããéã«éåããé ããã£ãŠããŸããããããªãã
ããããããããæ¹ã«äœãšèšãã°ããã®ããããã§ãã£ãšæ©ãã§ããã
ãã®ã¢ã€ã¢ã€ãå°ããšããã®ãJAMA Oncologyãžåºã1æ¬ã®è«æã ã£ãã
ä»åã¯ãã®è«æãããšã«ããžã ã«è¡ããªã人ã®ããäºé²ãšVILPAã«ã€ããŠæžããŠã¿ãã
VILPAãšã¯ãçæŽ»ã®äžã«çŽãããã ãçããã©æ¿ããèº«äœæŽ»åã®ããšã ã
ãéåã®ã€ãŸã¿é£ããã¿ãããªãã®ã
åã«éåãšããã®èšäºãæžãããå€§è žããã®æè¡ãšæããå€ãçµãã人ã察象ã«ããCHALLENGE詊éšã§ã¯ãéåããã°ã©ã ãåãã人ãã¡ã§åçºã»æ»äº¡ãå°ãªãã£ã²âŸããã ãããã¯ããã«ããªã£ãŠãããã®è©±ã ã£ãã
仿¥ã®è©±ã¯ãããã«ããªãåãã®è©±ã ãããã«ãªãåã«ãã©ãäºé²ããããéåç¿æ £ããªã人ã»ã©ãèªãã§ã¿ãŠã»ããã
éåãŒãã®2äžäººãã7幎远ãããã
ç ç©¶ããŒã ã察象ã«ããã®ã¯ããèªåã¯éåããŠããªãããšçããæäºº22,398人ãããã§ã®ãéåããŠããªããã¯ããžã ãã¹ããŒãã®ç¿æ
£ããªããšããæå³ã ã ãŸã£ããåããªã人ããšããæå³ã§ã¯ãªãã
ãããããéåããŠããªã人ãã¯ãçæŽ»ã®äžã§ã¯æå€ã«åããŠããããšããããããšãã°ãé§
ã®éæ®µãæ¥ãã§äžãããéãè²·ãç©è¢ãéã¶ãåã©ããç¬ãšçãèµ°ãããã¹ã«éã«åãããã«æ©æ©ãããã
ãããã1åååŸã®çãé«åŒ·åºŠã®åãããæ¬äººãæ°ã¥ããªããã¡ã«ç掻ãžçŽãããã§ããããããVILPAã ãVILPAã«ã€ããŠã¯åã«ãå šå1åãšæ£æ©53åã®å¹æãã»ãŒåãã ã£ãããšããèšäºã§è©³ããæžããã
ãã ãããå
šåããšãã£ãŠããæå€§ã®åãåºãåããšããæå³ã§ã¯ãªãã
æ¯ãããªãäžãã£ãŠã ã²ãšæ¯å
¥ããªããšæ°èªãã話ããªã ãããã®åŒ·ãã ã
ä»åã®ç ç©¶ã§ã¯ããã®äººãã¡ã®æéŠã«ãŠã§ã¢ã©ãã«ãã€ããŠãå®éã®åããèšé²ããŠãããæ¬äººã®ç³åã§ã¯ãªããæ©æ¢°ã§æž¬ã£ãããŒã¿ã ããã®ããã§å¹³å6.7幎远ãããããããšèšºæãããäººãæ°ããã
1æ¥4.5åã®VILPAããã人ã§ã¯ãããçºçã2å²å°ãªãã£ã
VILPAãã»ãšãã©ãªã人ãåºæºã«ãããšã1æ¥4.5åã»ã©ã®VILPAããã人ã§ã¯ãããå šäœã®çºçãå°ãªãã£ãã
ãã¶ãŒãæ¯ã¯0.80ããã£ããèšãã°ã çºçã®ãããããçŽ2å²äœãã£ã³âŸã
4.5åãšãã£ãŠããé£ç¶ã§ããå¿
èŠã¯ãªãã
1å1åãããããªãçãåããã1æ¥ã®äžã§äœåãç©ã¿éãªã£ãåèšã ã
ãšã¹ã«ã¬ãŒã¿ãŒãéæ®µã«å€ããŠé§ãäžãã é§
ãŸã§å°ãå°èµ°ãã§æ¥ãã åéã§æ¯ãäžããã ãããäžæ¥äœåãããšãã話ã ã

ããã«ãèº«äœæŽ»åãšé¢é£ãæ·±ããšããã 13çš®é¡ ã®ããã«çµããšãå·®ã¯ããäžæ®µå€§ãããªã£ãã
ãã®13çš®ã«ã¯ã倧è
žã»ä¹³æ¿ã»åå®®äœã»èèã»èºã»è
èã»èè±ã»é£éã»èã»é é žéšã»è¡æ¶²ç³»ã®ããïŒéªšé«æ§çœè¡ç
ã»å€çºæ§éªšé«è
«ïŒãå«ãŸããã
ãããã«éããšã1æ¥4.5åã»ã©ã®VILPAããã人ã§ã¯ãçºç㯠çŽ3å²å°ãªãã£ã ããã¶ãŒãæ¯ã¯0.69ã ã£ã³âŸã
1æ¥30åã§ããªãã 1æéã§ããªãã åèšã§4.5åã ãã
ããã¯éåãèŠæãªäººã«ãšã£ãŠããªã倧ããã
ã¡ãªã¿ã«ãã¢ãã«äžã¯ãã£ãšå°ãªãéããé¢é£ãåºãŠããŠã1æ¥3.4åã®VILPAãããã§ããããå šäœã®ãã¶ãŒãæ¯ã¯0.83ïŒçŽ1.7岿žå°)ã ã£ãã
çæŽ»ã®äžã«ãçãæ¯ãäžããæŽ»åããã人ã»ã©ãããã®çºçãå°ãªãã£ãã
å°éçã«ãªã£ãŠããŸãããã©ãããã§å°ã泚æç¹ãããã
ããã¯ä»å
¥è©Šéšã§ã¯ãªãã VILPAãããããããããæžã£ãããšããç ç©¶ã§ã¯ãªããããšããšç掻ã®äžã«VILPAãå€ãã£ã人ã远ãããããããããå°ãªãã£ããããšãã芳å¯ç ç©¶ã ãã ããããã®ç ç©¶ã ããããæ°åã®å
šåã§ããã¯é²ããããšããå æé¢ä¿ãŸã§ã¯èšããªãã
ãšã¯ãããããšããžã ã«è¡ããªããŠããçæŽ»ã§äœåºŠãVILPAããããšã¯ããäºé²ã«ããªãæå³ãããããã ãšæãããç ç©¶ã ã
éåãšããäºé²ã¯ããã®è«æã ãã®è©±ã§ã¯ãªã
ãããŸã§VILPAã®æ°åã䞊ã¹ãŠãããã©ããããåã人ã»ã©ãããã«ãªãã«ããããšãã話ã¯ãœã£ãšåºã®ä»®èª¬ã§ã¯ãªãã
ãã£ãåºãŠãã13çš®é¡ã®ããããããšã¯ãã£ãšå€§ããªç ç©¶ããæ¥ãŠããã 144äžäºº åã®ããŒã¿ããŸãšããè§£æã§ã26çš®é¡ã®ããã調ã¹ããšããèº«äœæŽ»åãå€ã人ã»ã©çºçãå°ãªãããã13çš®é¡ãã£ãâŽâŸã
VILPAç ç©¶ã¯ããã®æµããä»åºŠã¯ãŠã§ã¢ã©ãã«ã§å®éã«ç¢ºããã圢ã«ãªãã
ãã ãããã®13çš®ãã¹ãŠã§èšŒæ ãåã匷ãããšããæå³ã§ã¯ãªãã
WCRF/AICRïŒäžçããç ç©¶åºéã»ç±³åœããç ç©¶æïŒã¯ãäžç床ããé«åŒ·åºŠã®èº«äœæŽ»åã«ãã£ãŠå€§è žããã®ãªã¹ã¯ãäœããªãããšãã確å®ã ãšè©äŸ¡ããŠãããéçµåŸä¹³ãããåå®®äœãã㯠ãã»ãŒç¢ºå®ããé«åŒ·åºŠã®èº«äœæŽ»åã«ããéçµåä¹³ããã®ãªã¹ã¯äœäžããã»ãŒç¢ºå®ããšãããŠããâµâŸã
ã€ãŸãããšããã³ã¹ããã¡ã°ã匷ãã®ã¯å€§è žããã ã
æ¥æ¬äººã®ããŒã¿ã«çµããšãè©äŸ¡ã¯å°ãæ
éã«ãªããåœç«ããç ç©¶ã»ã³ã¿ãŒã¯ãèº«äœæŽ»åã«ãã£ãŠå€§è
žããã®ãªã¹ã¯ãäœããªãããšããã»ãŒç¢ºå®ããä¹³ããããå¯èœæ§ãããããšããŠããâ¶âŸãäžçã®è©äŸ¡ã»ã©ãåºãã¯èšãåã£ãŠããªãã
ãã ããã®å€§è
žããã¯ã æ¥æ¬äººã®ããçœ¹æ£æ°ãæãå€ããã ã â·âŸã ãããŠãéåãšã®é¢é£ããã¡ã°ã匷ãã
倿¥ã§ã倧è
žãããå¿é
ã ãšãã人ã¯å€ãã®ã ãã©ãèªåã¯å€§è
žå
èŠé¡æ€æ»ã«å ããŠãããªãèªä¿¡ãæã£ãŠéåãããããŠããã
ãã®ããã«ããåããŠãã人ã»ã©ãããã«ãªãã«ããããšãã倧ããªæµãã¯ããªãæç¢ºã«ãªã£ãŠããŠããã VILPAãæ°ããã®ã¯ãããã«ããžã ã«è¡ããªã人ã®ãçæŽ»ã®äžã®æ°åã§ãããšããçŸå®çãªè§£ãäœã£ãããšã ãšæãã
ãªãããã£ãæ°åã§å·®ãã€ãã®ã
ãã®ç ç©¶ã¯ãçç±ãŸã§èšŒæããããã§ã¯ãªãã
ã ããããããã¯ä»ãŸã§ã®åºç€ç ç©¶ãèžãŸãã仮説ã ã

ãŸããã€ã³ã¹ãªã³ã ã
ã€ã³ã¹ãªã³ã¯è¡ç³ãäžãããã«ã¢ã³ã ãã现èã«ãå¢ããããšåœããé¡ãæã£ãŠãããIGF-1ãšããè¿ã仲éãã现è墿®ã«é¢ããã
éåãããšãçèãç³ãåã蟌ã¿ããããªãã ã€ã³ã¹ãªã³ã®å¹ãããããªãã ãããšãè¡ç³ãäžããããã«å€§éã®ã€ã³ã¹ãªã³ãåºãç¶ããªããŠãããªãããã现èã«ãšã£ãŠã®å¢æ®ã·ã°ãã«ããå°ã匱ãŸããããããªãã
次ã«ãçèãã®ãã®ã ã
çèã¯ããã äœãåããéšåã§ã¯ãªããåããã³ã«ã ãã€ãªã«ã€ã³ ãšåŒã°ããããŸããŸãªç©è³ªãè¡æ¶²äžãžæŸåºããèåšã§ããããçèãåãããšã§ãççãå
ç«ã代è¬ãå€ããã ããã®èœãè²ã¡ãããç°å¢ããå°ãå€ããå¯èœæ§ãããã
ããã²ãšã€ã¯ãæ
¢æ§ççã ã
éåäžè¶³ãå
èèèªã«äŒŽãæ
¢æ§ççããããã®çºçã«é¢ããå¯èœæ§ãææãããŠãããéåã¯ããã®æ
¢æ§ççãæããŠãããã
ãã¡ããã1æ¥æ°åã®VILPAã§ãããããã©ããŸã§å€ããã®ãã¯ãŸã ããããªãã匷床ãå¹ããŠããã®ããç·æŽ»åéãå¹ããŠããã®ããããŸã 決çããŠããªããå¥ã®UK Biobankè§£æã§ã¯ãç·æŽ»åéãæ©æ°ã§ãåãæ¹åã®é¢é£ãå ±åãããŠããâžâŸã
ãã ããç©ããããã§ãããã ãã§ã¯èª¬æããããªãã ä»åã®VILPAã¯ãäœéã倧ããåããã»ã©ã®éã§ã¯ãªãããã ãäœéãå€ãããªããŠããçèãåããè¡ç³å€ãäžãããççãæžãã
ããã§ãã芳å¯ç ç©¶ã®éçããã

ããã¯å€§äºãªã®ã§ããäžåºŠã ãæžããŠããããããã®ç ç©¶ã¯ãVILPAãããããŠãããæžãããèŠãç ç©¶ã§ã¯ãªãã ããšããšVILPAãå€ãã£ã人ã远ã£ããããããå°ãªãã£ããšããç ç©¶ã ãããã®å Žåãç¹ã«ãããããã
ããã¯ãèŠã€ãããã£ãšåããæ°Žé¢äžã§è²ã£ãŠããããšãããã
ãŸã 蚺æãããŠããªããããããã§ã«äœåãåã£ãŠãããšããã
ãããšããã®äººã¯éæ®µãæ¥ãã§äžãããªããªãã æ©æ©ããããªããªãã æ¯ãäžããåããé¿ããããã«ãªããçµæãšããŠããVILPAãå°ãªã人ã«ãããå€ããããã«èŠãããã€ãŸãã åå ãšçµæãéãããããªãã
ç ç©¶åŽãããã§ã«ããããã£ã人ãããŠã§ã¢ã©ãã«æž¬å®åŸ1幎以å ã«ããã«ãªã£ã人ãé€ããªã©ãã§ãã察çã¯ããŠãã³âŸãããã§ãå®å šã«ã¯æ¶ããªãã
ããã«ãçæŽ»ã®äžã§æ¯ãäžããåããã§ãã人ã¯ãããããäœåãããã
å¥åº·æèãé«ããããããªããé£äºãç¡ç ãå«ç
ãéããããããªãã
ã ããããã®èšäºã®çµè«ã¯ããã ã
ãVILPAãããã°ãããé²ãããã§ã¯ãªãã
ãçæŽ»ã®äžã«VILPAããã人ã§ã¯ããããå°ãªãã£ããã ã
ãã®å·®ã¯å€§ãããã§ããèªåã¯ããã§ãååã ãšæã£ãŠããã
éæ®µãå°ãéãäžããã®ã«ããéã¯ãããªãã ãžã ããããªãã
ç¹å¥ãªéå
·ããããªãã è¬ã®ãããªå¯äœçšããªãã
ãã¡ãããå¿èç ããã人ãè¡å§ãé«ã人ãããããªãå šåãåºãã®ã¯å¥ã ããããã¯æ³šæããããã§ãå€ãã®äººã«ãšã£ãŠãçæŽ»ã®äžã«VILPAãè¶³ãããšã¯ãçŸå®çã§ãã¿ãã§ã仿¥ããã§ããã
ããã«æå³ããããããªãããããªãçç±ã¯ããŸããªãã
ããããäœãããã°ããã
ç¹å¥ãªããšã¯ãããªãããŒãã1ã«ãã ããšã
éåç¿æ
£ããªã人ã«ããããªãé±300åã¯éçŸå®çãããã
ã§ãã1æ¥æ°åãªã話ãå€ããã
æ¯ãããªãäžããã ç¶ããŠè©±ãã®ããã€ãã å°ãæ¢ãŸã£ãŠåŒåžãæŽããããªããããããç¬éãã1æ¥ã«äœåãäœãã ããã ãã§ããã
éæ®µãåéãå°ãéãäžãã
å¹³å°ã3åã ãå°ããã€ãããŒã¹ã§æ©æ©ããã
è²·ãç©åž°ãã«å°ãã ãæ©ãããŒã¹ãäžãã
åã©ããç¬ãšãçãæ¬æ°ã§éã¶
ã©ããã ãžã ã«è¡ããªããŠãçæ¿ããªããŠãã§ããã
ãå
šåãªããŠç¡çããšãã人ã¯ãéæ©ããã§ããã
3åã ãå°ãéãæ©ãã3åãã£ããæ©ãããŸã3åéãæ©ãããããç¹°ãè¿ãã€ã³ã¿ãŒãã«éæ©ã§ãã倪ããã®çåãã€ããè¡å§ãäžãã£ãŠãããããæ¹ã¯ãã®èšäºã«æžããã
â ïž ãã ããé«åŒ·åºŠã®éåã¯å šå¡ã«å®å šãªããã§ã¯ãªããå¿èã«æç ããã人ãè¡å§ãé«ããŸãŸã®äººãé·ãéåããé¢ããŠãã人ãããããªãæ¯ã倧ããäžããéåãããã®ã¯å±ãªãã§ããèžã®çã¿ãåŒ·ãæ¯åããããŸããåæžããã人ãåããåœãŠã¯ãŸã人ã¯ã䞻治å»ã«çžè«ããŠããå§ããããã«ããŠãã ããã
ãšã¹ã«ã¬ãŒã¿ãŒã§ã¯ãªãéæ®µã ãã£ããæ©ãã§ã¯ãªãã3åã ãæ©æ©ãã
ã ãã ãåéã§ã¯ãªããå°ãæ¯ãäžããåéã
ããäºé²ã®éåã¯ããžã ããå§ããªããŠããã
ãŒãã1ã«ããã ãã®1ã¯ããã¶ãæã£ãŠããããå°ãããŠããã
ãŸãšã
éåããŠããªãæäºº2.2äžäººãå¹³å6.7幎远ããšã1æ¥4.5åã»ã©ã®VILPAããã人ã§ã¯ãããå šäœã®çºçãçŽ2å²ãèº«äœæŽ»åãšé¢é£ãæ·±ã13çš®ã§ã¯çŽ3å²å°ãªãã£ã
ããã¯èгå¯ç ç©¶ãªã®ã§ããããã°ãããæžãããšèšŒæãããã®ã§ã¯ãªãã
ããã§ããèº«äœæŽ»åãšããäºé²ã®é¢ä¿ã¯1æ¬ã®è«æã ãã®è©±ã§ã¯ãªãã
å€§è žãããäžå¿ã«ãããªã匷ã蚌æ ãããéåç¿æ £ããªã人ã«å€§äºãªã®ã¯ããŸããŒãã1ã«ããããšã
1æ¥ã«æ°åãæ¯ããã£ããäžããç¬éãäœããããããã§ãã
ãããŸã§èªãã§ãã ãã£ãŠãããããšãããããŸããã
圹ã«ç«ã£ãããã¹ããããããããšããããå±ã¿ã«ãªããŸãã
èªåã®äœã§ã詊ããå¥åº·ã®è©±ããããããªããŒãã§ãæ°æ¥ã«1æ¬ãããåºããŠããŸãããã²ãã©ããŒããŠããããšå¬ããã§ãã
ãã£ãšæ·±ãç¥ãããæ¹ãžïŒé¢é£èšäºïŒ
ãã®èšäºã¯ããªãåãã®è©±ã§ããéå以å€ã®äºé²ãšããã®å ã®è¡ç³ã®è©±ã玹ä»ããŸãã
⌠éå以å€ã§ãããäºé²ã«ãè¶³ããåã«
ãããäºé²ãµããªãããŸããããšèãããŠãèªåãå°ã£ã話ïŒç¡æïŒ
éåã«ã¯è¶³ã䟡å€ããããŸãããã§ã¯ãµããªã¯ããšæã£ãæ¹ãžãå«ç
è
ãβã«ããã³ã飲ãã ãèºãããå¢ãã話ãããè¶³ãåã«ãŸãäœãåããã®é çªãæžããŠããŸãã
⌠è¡ç³ãããã€ãäžããã
è¡ç³ã¯ããã€æ©ãããã§æ±ºãŸãïŒã¡ã³ããŒéå®ïŒ ã€ã³ã¹ãªã³ãäžãã£ã±ãªãã«ããªãããšããä»åã®æ©åºã®ç¶ãã§ãããªãã¬ã2é±éã€ããŠãé£åŸã®è¡ç³ãæ©ãã¿ã€ãã³ã°ã§ã©ãåãããã確ãããŠããŸãã
ã¡ã³ããŒã·ãããDr.ãããã©ããã®ãç¥ãã
ã¡ã³ããŒã·ãããDr.ãããã©ãããéå¶ããŠããŸããXã»ç¡ænoteã§ã¯åºããªããããäžæ®µèžã¿èŸŒãã è©±ãæžããŠããŸãã
çµå¶è ã®äž»æ²»å»ãšããŠã倿¥ã§å®éã«è©±ããŠããå 容
è«æãèªã¿ãªããèªåã®äœã§è©Šãããå¹ããã»å¹ããªãã£ãèšé²
æ€æ»æ°å€ã®èªã¿æ¹ããµããªã»è¬ã®éžã³æ¹
ã¡ã³ããŒéå®ã®æ²ç€ºæ¿Q&A
æé¡1000åã§å šèšäºèªã¿æŸé¡ã§ããåããªãã£ããããè§£çŽã§ããŸããæ°ã«ãªã£ãæ¹ã¯ãèŠããŠã¿ãŠãã ããã
â»æ¬èšäºã¯äžè¬çãªå¥åº·ã»å»åŠæ å ±ã®æäŸãç®çãšãããã®ã§ãããç¹å®ã®å人ã«å¯Ÿãã蚺æã»æ²»çã»å»åŠçå©èšãè¡ããã®ã§ã¯ãããŸãããå¥åº·äžã®æžå¿µãããå Žåã¯ãå¿ ãå»çæ©é¢ãå蚺ããŠãã ãããèšäºã®æ å ±ã«åºã¥ãè¡åã®çµæã«ã€ããŠã¯ãçè ã¯è²¬ä»»ãè² ããããŸãã
åèæç®
1) Stamatakis E, Ahmadi MN, et al. Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study. JAMA Oncol. 2023;9(9):1255-1259. doi:10.1001/jamaoncol.2023.1830
2) Moore SC, Lee IM, Weiderpass E, et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Intern Med. 2016;176(6):816-825. doi:10.1001/jamainternmed.2016.1548
3) World Cancer Research Fund / American Institute for Cancer Research. Be physically active: evidence for our recommendationsïŒphysical activity and cancerïŒ. wcrf.orgïŒ2025æŽæ°ïŒ.
4) Shreves AH, Small SR, Walmsley R, et al. Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank. Br J Sports Med. 2025;59(12):839-847. doi:10.1136/bjsports-2024-109360
5) Papadimitriou N, Dimou N, Tsilidis KK, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11(1):597. doi:10.1038/s41467-020-14389-8